CPH 0.00% 0.9¢ creso pharma limited

Ann: Appendix 4E and Annual Report to Shareholders, page-11

  1. 694 Posts.
    lightbulb Created with Sketch. 132
    This post cannot be any clearer....

    CPH has got some good assets and footing in the market but its not the right team to take it there because its just plain simple.. conflict of interest on the board level.. something that has been highlighted for YEARS.... its really not hard when you look at where money is being spent on..

    and to some thinking this ASIC investigation is going to remove Adam.B. This latest cap raise clearly shows it is not the case.

    IMO (and I believe that's why William Lay was brought in too).. they are looking to hype this up and search/hope for a takeover offer..


    Last edited by edwardc: 01/03/22
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.